Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Systemic delivery of a TLR7 agonist in combination with radiation primes durable antitumor immune responses in mouse models of lymphoma

Simon J. Dovedi, Monique H. M. Melis, Robert W. Wilkinson, Amy L. Adlard, Ian J. Stratford, Jamie Honeychurch, Timothy M. Illidge

Blood (2013) 121 (2): 251–259.

https://doi.org/10.1182/blood-2012-05-432393

Published: 2013

Includes: Supplemental data

Journal Articles

Antibody-induced nonapoptotic cell death in human lymphoma and leukemia cells is mediated through a novel reactive oxygen species-dependent pathway

Jamie Honeychurch, Waleed Alduaij, Mahsa Azizyan, Eleanor J. Cheadle, Helene Pelicano, Andrei Ivanov, Peng Huang, Mark S. Cragg, Tim M. Illidge

Blood (2012) 119 (15): 3523–3533.

https://doi.org/10.1182/blood-2011-12-395541

Published: 2012

Includes: Multimedia, Supplemental data

Journal Articles

Antibody-Induced Non-Apoptotic Cell Death in Human Lymphoma and Leukemia Cells Is Mediated Through NADPH Oxidase-Derived Reactive Oxygen Species

Jamie Honeychurch, PhD, Waleed Alduaij, MRes, Eleanor Cheadle, PhD, Mahsa Azizyan, MSc, Helene Pelicano, PhD, Peng Huang, MD PhD, Andrei Ivanov, MD PhD, Mark S Cragg, PhD, Timothy M Illidge, MD, PhD

Blood (2011) 118 (21): 1651.

https://doi.org/10.1182/blood.V118.21.1651.1651

Published: 2011

Journal Articles

Novel type II anti-CD20 monoclonal antibody (GA101) evokes homotypic adhesion and actin-dependent, lysosome-mediated cell death in B-cell malignancies

Waleed Alduaij, Andrei Ivanov, Jamie Honeychurch, Eleanor J. Cheadle, Sandeep Potluri, Sean H. Lim, Kazuyuki Shimada, Claude H. T. Chan, Alison Tutt, Stephen A. Beers, Martin J. Glennie, Mark S. Cragg, Tim M. Illidge

Blood (2011) 117 (17): 4519–4529.

https://doi.org/10.1182/blood-2010-07-296913

Published: 2011

Includes: Multimedia, Supplemental data

Journal Articles

Anti-HLA-DR Monoclonal Antibody Evokes a Novel Non-Apoptotic Cell Death Pathway In Acute Lymphoblastic Leukemia

Khimara Naidoo, Waleed Alduaij, Jamie Honeychurch, Eleanor Cheadle, Seema Alexander, Richard Byers, Vaskar Saha, Tim Illidge

Blood (2010) 116 (21): 3245.

https://doi.org/10.1182/blood.V116.21.3245.3245

Published: 2010

Journal Articles

New-Generation Anti-CD20 Monoclonal Antibody (GA101) Evokes Homotypic Adhesion and Actin-Dependent, Lysosome-Mediated Cell Death in B-Cell Lymphoma.

Waleed Alduaij, MRes, Sandeep Potluri, BA, Andrei Ivanov, PhD, Jamie Honeychurch, PhD, Stephen A Beers, PhD, Claude Chan, PhD, Kazayuki Shimada, MD, Martin J. Glennie, PhD, Mark S Cragg, PhD, Tim Illidge, MD, PhD

Blood (2009) 114 (22): 725.

https://doi.org/10.1182/blood.V114.22.725.725

Published: 2009

Journal Articles

Macrophage Depletion Can Enhance Combined Radiation and Anti-CD40 Monoclonal Antibody Therapy of B-Cell Lymphoma.

Jamie Honeychurch, PhD, Tim M. Illidge, MD, PhD

Blood (2006) 108 (11): 2501.

https://doi.org/10.1182/blood.V108.11.2501.2501

Published: 2006

Journal Articles

Cyclophosphamide Induced CD11b + Cells Can Inhibit Anti-CD40 Monoclonal Antibody (mAb) Therapy of B-Cell Lymphoma.

Jamie Honeychurch, PhD, Martin J. Glennie, PhD, Peter W. Johnson, MD, Tim M. Illidge, MD, PhD

Blood (2004) 104 (11): 3280.

https://doi.org/10.1182/blood.V104.11.3280.3280

Published: 2004

Journal Articles

Antibody-induced intracellular signaling works in combination with radiation to eradicate lymphoma in radioimmunotherapy

Yong Du, Jamie Honeychurch, Mark S. Cragg, Mike Bayne, Martin J. Glennie, Peter W. M. Johnson, Tim M. Illidge

Blood (2004) 103 (4): 1485–1494.

https://doi.org/10.1182/blood-2003-06-2037

Published: 2004

Journal Articles

Anti-CD40 monoclonal antibody therapy in combination with irradiation results in a CD8 T-cell–dependent immunity to B-cell lymphoma

Jamie Honeychurch, Martin J. Glennie, Peter W. M. Johnson, Timothy M. Illidge

Blood (2003) 102 (4): 1449–1457.

https://doi.org/10.1182/blood-2002-12-3717

Published: 2003

Journal Articles

Therapeutic efficacy of FcγRI/CD64-directed bispecific antibodies in B-cell lymphoma

Jamie Honeychurch, Alison L. Tutt, Thomas Valerius, Ingmar A. F. M. Heijnen, Jan G. J. Van de Winkel, Martin J. Glennie

Blood (2000) 96 (10): 3544–3552.

https://doi.org/10.1182/blood.V96.10.3544

Published: 2000

NARROW

Systemic delivery of a TLR7 agonist in combination with radiation primes durable antitumor immune responses in mouse models of lymphoma

Antibody-induced nonapoptotic cell death in human lymphoma and leukemia cells is mediated through a novel reactive oxygen species-dependent pathway

Antibody-Induced Non-Apoptotic Cell Death in Human Lymphoma and Leukemia Cells Is Mediated Through NADPH Oxidase-Derived Reactive Oxygen Species

Novel type II anti-CD20 monoclonal antibody (GA101) evokes homotypic adhesion and actin-dependent, lysosome-mediated cell death in B-cell malignancies

Anti-HLA-DR Monoclonal Antibody Evokes a Novel Non-Apoptotic Cell Death Pathway In Acute Lymphoblastic Leukemia

New-Generation Anti-CD20 Monoclonal Antibody (GA101) Evokes Homotypic Adhesion and Actin-Dependent, Lysosome-Mediated Cell Death in B-Cell Lymphoma.

Macrophage Depletion Can Enhance Combined Radiation and Anti-CD40 Monoclonal Antibody Therapy of B-Cell Lymphoma.

Cyclophosphamide Induced CD11b + Cells Can Inhibit Anti-CD40 Monoclonal Antibody (mAb) Therapy of B-Cell Lymphoma.

Antibody-induced intracellular signaling works in combination with radiation to eradicate lymphoma in radioimmunotherapy

Anti-CD40 monoclonal antibody therapy in combination with irradiation results in a CD8 T-cell–dependent immunity to B-cell lymphoma

Therapeutic efficacy of FcγRI/CD64-directed bispecific antibodies in B-cell lymphoma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only